Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence?

Cancer

Volumn 106, Issue 3, 2006, Pages 576-580

  Vickers, Andrew J ^a   Bianco Jr , Fernando J ^a   Boorjian, Stephen ^a   Scardino, Peter T ^a   Eastham, James A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Diagnosis; Pathology; Prostatectomy; Prostatic neoplasms; Recurrence; Survival

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NOMOGRAM; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PATIENT COUNSELING; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROSTATE CARCINOMA; PROSTATECTOMY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; UNITED STATES;

AGED; BIOPSY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 31544449183     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21643     Document Type: Article

References (10)

1. Nguyen PL, Whittington R, Koo S, et al. The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma. Cancer. 2005;103:2053-2059.
2. Nam RK, Jewett MA, Krahn MD, et al. Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy. Can J Urol. 2003;10:1891-1898.
3. Moul JW, Leon S, Amling CL, et al. How long can radical prostatectomy (RP) safely be delayed? CPDR's experiences from 3324 cases. J Urol 2004;171(Suppl):312.
4. Khan MA, Mangold LA, Epstein JI, Boitnott JK, Walsh PC, Partin AW. Impact of surgical delay on long-term cancer control for clinically localized prostate cancer. J Urol. 2004;172(5 Pt 1):1835-1839.
5. Beahrs O, Henson D, Hutter R. American Joint Committee on Cancer: manual for staging cancer, 4th edition. Philadelphia: J.B. Lippincott, 1992.
6. Graefen M, Karakiewicz PI, Cagiannos I, et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 2002;20:3206-3212.
7. Robertson C, Robertson AG, Hendry JH, et al. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys. 1998;40:319-329.
8. Sainsbury R, Johnston C, Haward B. Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis. Lancet. 1999;353:1132-1135.
9. Roncoroni L, Pietra N, Violi V, Sarli L, Choua O, Peracchia A. Delay in the diagnosis and outcome of colorectal cancer: a prospective study. Eur J Surg Oncol. 1999;25:173-178.
10. Epstein JI, Walsh PC, Carter HB. Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage T1c disease. J Urol. 2001;166:1688-1691.